Systems and methods for controlling inflammatory response
First Claim
1. A method for controlling systemic inflammatory response in a patient, the method comprising the steps of:
- deploying a reduced-pressure treatment device proximate an internal tissue site;
wherein the internal tissue site is in an abdominal cavity interior to the patient'"'"'s peritoneum;
fluidly coupling an external reduced-pressure source to the reduced-pressure treatment device to provide reduced pressure proximate the internal tissue site;
providing reduced pressure from the external reduced-pressure source to the reduced-pressure treatment device;
treating a pro-inflammatory milieu at the internal tissue site to control systemic inflammatory response throughout the patient'"'"'s body; and
wherein the step of treating a pro-inflammatory milieu comprises removing pro-inflammatory stimuli proximate the internal tissue site.
7 Assignments
0 Petitions
Accused Products
Abstract
A method and system for controlling inflammatory response at an internal tissue site of a patient utilizes a reduced-pressure treatment device. Controlling the inflammatory response may be accomplished in a number of ways that involve treating the inflammatory milieu. Treating the inflammatory milieu may include removing or moderating pro-inflammatory stimuli, e.g., fluids, enhancing perfusion of the tissue at or near the internal tissue site, or providing reduced-pressure therapy. The reduced-pressure treatment device is placed at or near the internal tissue site and is fluidly coupled to an external reduced-pressure source. The reduced-pressure treatment device provides reduced pressure proximate the tissue site and treats the inflammatory milieu. The reduced-pressure treatment device for controlling inflammatory response may be a minimally-invasive treatment device.
249 Citations
16 Claims
-
1. A method for controlling systemic inflammatory response in a patient, the method comprising the steps of:
-
deploying a reduced-pressure treatment device proximate an internal tissue site; wherein the internal tissue site is in an abdominal cavity interior to the patient'"'"'s peritoneum; fluidly coupling an external reduced-pressure source to the reduced-pressure treatment device to provide reduced pressure proximate the internal tissue site; providing reduced pressure from the external reduced-pressure source to the reduced-pressure treatment device; treating a pro-inflammatory milieu at the internal tissue site to control systemic inflammatory response throughout the patient'"'"'s body; and wherein the step of treating a pro-inflammatory milieu comprises removing pro-inflammatory stimuli proximate the internal tissue site. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
Specification